Kristell L.S. Chatalic

A Novel ¹¹¹In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer

Kristell L.S. Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein et al. · Journal of Nuclear Medicine · 2015 · 132 citations · Full text

Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent

Kristell L.S. Chatalic, Sandra Heskamp, Mark Konijnenberg et al. · Theranostics · 2016 · 121 citations · Full text

Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists

Maikel Wijtmans, David Maussang, Francesco Sirci et al. · European Journal of Medicinal Chemistry · 2012 · 68 citations · Full text

Molecular Pharmacology, Functional Activity, Medicine +11

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

Kristell L.S. Chatalic, Mark Konijnenberg, Julie Nonnekens et al. · Theranostics · 2015 · 67 citations · Full text

Urology, Engineering, Medicine +15

²¹³ Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts

Julie Nonnekens, Kristell L.S. Chatalic, Janneke D.M. Molkenboer‐Kuenen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2017 · 56 citations · Full text